Abstract
Patients with chronic liver disease are at increased risk of developing hepatocellular carcinoma (HCC). Most patients diagnosed with HCC have limited treatment options and a poor overall prognosis, with a 5-year survival less than 15%. Preventing the development of HCC represents the most important strategy. However, current guidelines lack specific recommendations for primary prevention. Lifestyle factors may be central in the pathogenesis of HCC, and primary prevention strategies focused on lifestyle modification could represent an important approach to the prevention of HCC. Both experimental and epidemiologic studies have identified promising chemopreventive agents for the primary prevention of HCC.
Original language | English |
---|---|
Pages (from-to) | 549-576 |
Number of pages | 28 |
Journal | Clinics in Liver Disease |
Volume | 24 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2020 |
Externally published | Yes |
Keywords
- Cancer prevention
- Chemoprevention
- Hepatocellular carcinoma
- Lifestyle
- Modifiable risk factor